459 related articles for article (PubMed ID: 1838064)
1. Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women.
al-Muhtaseb N; al-Yusef AR; Bajaj JS
Diabet Med; 1991 Oct; 8(8):732-7. PubMed ID: 1838064
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
[TBL] [Abstract][Full Text] [Related]
3. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A-I, A-II, B, C-II, and C-III in children with insulin-dependent diabetes mellitus.
al Muhtaseb N; al Yousuf A; Bajaj JS
Pediatrics; 1992 May; 89(5 Pt 1):936-41. PubMed ID: 1579407
[TBL] [Abstract][Full Text] [Related]
5. Relation of abnormal composition of lipoproteins to HbA1c levels in non-insulin dependent diabetes.
Sánchez-Cabezudo M; Ródenas S; Cuesta C
Rev Esp Fisiol; 1994 Sep; 50(3):145-51. PubMed ID: 7886271
[TBL] [Abstract][Full Text] [Related]
6. [Correlations of the levels of HbA1c with plasma apoproteins and plasma lipoproteins in type II diabetic patients].
Ródenas S; Sánchez-Cabezudo M; Cuesta C
Rev Esp Fisiol; 1993 Mar; 49(1):23-9. PubMed ID: 8378574
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide.
Billingham MS; Milles JJ; Bailey CJ; Hall RA
Diabetes Res; 1989 May; 11(1):13-20. PubMed ID: 2515931
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein abnormalities in well-treated type II diabetic patients.
Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
[TBL] [Abstract][Full Text] [Related]
9. [Lipoprotein and apolipoprotein levels in young insulin-dependent diabetic patients. Relations with glycosylated hemoglobin and fructosamine].
Willems D; Dorchy H
Presse Med; 1990 Jan 6-13; 19(1):17-20. PubMed ID: 2137219
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.
Manzato E; Zambon A; Zambon S; Nosadini R; Doria A; Marin R; Crepaldi G
Acta Diabetol; 1993; 30(1):11-6. PubMed ID: 8329725
[TBL] [Abstract][Full Text] [Related]
11. Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns.
Averna MR; Barbagallo CM; Di Paola G; Labisi M; Pinna G; Marino G; Dimita U; Notarbartolo A
Biol Neonate; 1991; 60(3-4):187-92. PubMed ID: 1797121
[TBL] [Abstract][Full Text] [Related]
12. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551
[TBL] [Abstract][Full Text] [Related]
13. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
[TBL] [Abstract][Full Text] [Related]
14. Metabolic control affects plasma lipid and apolipoprotein levels in women, but not in men, with IDDM.
Benzi L; Marchetti P; Giampietro O; Miccoli R; Pecori N; Sanna G; Caricato F; Giovannitti MG; Ciccarone AM; Navalesi R
Acta Diabetol Lat; 1988; 25(2):149-54. PubMed ID: 3223190
[TBL] [Abstract][Full Text] [Related]
15. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
Briones ER; Mao SJ; Palumbo PJ; O'Fallon WM; Chenoweth W; Kottke BA
Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
[TBL] [Abstract][Full Text] [Related]
16. Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus.
Attia N; Touzani A; Lahrichi M; Balafrej A; Kabbaj O; Girard-Globa A
Diabet Med; 1997 Mar; 14(3):242-7. PubMed ID: 9088774
[TBL] [Abstract][Full Text] [Related]
17. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
Prager R; Schernthaner G; Kostner GM; Mühlhauser I; Zechner R; Dorda W
Atherosclerosis; 1982 Jun; 43(2-3):321-7. PubMed ID: 6810904
[TBL] [Abstract][Full Text] [Related]
18. The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks.
Fontvieille AM; Rizkalla SW; Penfornis A; Acosta M; Bornet FR; Slama G
Diabet Med; 1992 Jun; 9(5):444-50. PubMed ID: 1611832
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
Idzior-Walus B; Mattock MB; Solnica B; Stevens L; Fuller JH;
Diabet Med; 2001 Oct; 18(10):786-96. PubMed ID: 11678968
[TBL] [Abstract][Full Text] [Related]
20. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?
Alagözlü H; Gültekin F; Candan F
Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
